Thioridazine-associated immune hemolytic anemia.
An association between the ingestion of 72 gm of thioridazine over a 31-month period and immune hemolytic anemia is reported, with a schematic presentation of drug treatment and hematopoietic response during hospitalization.
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D013881:Thioridazine / Q000009:adverse effects*
D013881:Thioridazine